ProShares listed EQQQ on Thursday, a fund that targets twice the daily return of the Nasdaq 100 Equal-Weighted Index. It's the first ETF of its kind, and it takes direct aim at a frustration that has been building among investors for years: the standard Nasdaq 100 is so top-heavy that a handful of mega-cap tech names effectively drive the whole thing.

The fix EQQQ offers is straightforward. It holds the same 100 companies as the regular index but gives each one an identical slice of the portfolio. Every quarter, the weights reset. That means a mid-sized software firm carries exactly as much influence as the largest chip company on any given rebalancing day. For investors who have watched concentration risk bite into returns when top names disappoint, that's a meaningful structural difference.

The use side of the equation

The 2x multiplier cuts both ways. A strong day in the equal-weighted index delivers double the gain; a rough session delivers double the loss. ProShares is explicit that EQQQ is built as a daily trading tool. Holding it across multiple days, particularly through choppy markets, can cause actual returns to drift from the stated 2x target because of the compounding math that works against leveraged funds over time.

ProShares CEO Michael Sapir framed the launch as an answer to investors who want magnified Nasdaq exposure without betting so heavily on the index's biggest names. The fund carries a net expense ratio of 0.95% and slots into a ProShares lineup that spans more than $112 billion in ETF and mutual fund assets. Within that roster sits UltraPro QQQ, which Morningstar data from June 2026 ranked as the world's largest leveraged ETF. EQQQ now sits alongside it as a structurally distinct alternative.

ProShares has been building leveraged and inverse products since 2006, and the firm positions itself as the global leader in that category. Whether EQQQ attracts serious assets will depend on how much appetite there is for equal-weight construction among traders who already reach for leveraged Nasdaq tools.

This article is for informational purposes only and does not constitute financial or investment advice.